Trauma-informed, Resilience-based Telehealth Intervention for Improving HIV Prevention and HCV Care for Persons Who Inject Drugs in the Deep South (Formative Phase)
Enrolling by invitationOBSERVATIONAL
Enrollment
45
Participants
Timeline
Start Date
August 15, 2025
Primary Completion Date
October 31, 2025
Study Completion Date
November 30, 2025
Conditions
HIV Pre-exposure ProphylaxisHEPATITIS C (HCV)
Trial Locations (1)
30628
MedLink Georgia, Colbert
All Listed Sponsors
collaborator
National Institute on Drug Abuse (NIDA)
NIH
lead
University of Georgia
OTHER
NCT06799702 - Trauma-informed, Resilience-based Telehealth Intervention for Improving HIV Prevention and HCV Care for Persons Who Inject Drugs in the Deep South (Formative Phase) | Biotech Hunter | Biotech Hunter